Cite
HARVARD Citation
Sabrina, P. et al. (2018). Anti-apolipoprotein A1 (APOA1) autoantibodies disrupt the cholesterol pathway via SREBP-2 and decrease circulating MIR-33A in hypercholesterolaemic children. Atherosclerosis. pp. e42-e43. [Online].